Skip to content

THC THERAPEUTICS, INC.: 10-K filed 2014-06-09

What THC THERAPEUTICS, INC. reported in its annual report filed 2014-06-09 (fiscal FY 2013): 21 published measures, 65 facts as tagged in accession 0001606808-14-000019.

This filing

Form
10-K (annual report)
Filed
2014-06-09
Fiscal period
fiscal FY 2013
Accession
0001606808-14-000019 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All THC THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-07-31192,767USD
At 2012-07-31595,393USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-07-31145,714USD
At 2012-07-31389,381USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-07-3147,053USD
At 2012-07-31206,012USD
At 2011-07-31-64,936USD
At 2010-07-31-40,164USD
At 2009-07-31-68,510USD
At 2008-07-31363USD
At 2007-07-3116,072USD
At 2007-04-300USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-08-01 to 2013-07-31-111,246USD365
2007-05-01 to 2013-07-31-471,971USD2284
2011-08-01 to 2012-07-31-258,500USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-08-01 to 2013-07-310USD365
2007-05-01 to 2013-07-31200USD2284
2011-08-01 to 2012-07-310USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-08-01 to 2013-07-3170,000USD365
2007-05-01 to 2013-07-31662,171USD2284
2011-08-01 to 2012-07-31489,946USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-08-01 to 2013-07-310USD365
2007-05-01 to 2013-07-31-175,000USD2284
2011-08-01 to 2012-07-31-175,000USD366

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-08-01 to 2013-07-31214,167USD365
2007-05-01 to 2013-07-31214,167USD2284
2011-08-01 to 2012-07-310USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-08-01 to 2013-07-31-364,699USD365
2007-05-01 to 2013-07-31-837,606USD2284
2011-08-01 to 2012-07-31-240,352USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-07-3117,767USD
At 2012-07-3170,393USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-08-01 to 2013-07-310USD365
2007-05-01 to 2013-07-312,764USD2284
2011-08-01 to 2012-07-311,200USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-07-31145,714USD
At 2012-07-31214,381USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-08-01 to 2013-07-31364,699USD365
2007-05-01 to 2013-07-31837,806USD2284
2011-08-01 to 2012-07-31240,352USD366

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-07-311,701,489USD
At 2012-07-31282,489USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-07-3165,204USD
At 2012-07-3139,381USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2013-07-310USD
At 2012-07-310USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-08-01 to 2013-07-31-1,133,126USD365
2011-08-01 to 2012-07-31-241,552USD366
2010-08-01 to 2011-07-31-27,772USD365
2009-08-01 to 2010-07-31-37,864USD365
2008-08-01 to 2009-07-31-68,873USD365
2007-08-01 to 2008-07-31-15,709USD366
2007-05-01 to 2007-07-31-153USD92

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-08-01 to 2013-07-31-1,133,126USD365
2007-05-01 to 2013-07-31-1,522,049USD2284
2011-08-01 to 2012-07-31-241,552USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-08-01 to 2013-07-3119,736USD365
2007-05-01 to 2013-07-3140,977USD2284
2011-08-01 to 2012-07-3116,133USD366

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2012-08-01 to 2013-07-310USD365
2007-05-01 to 2013-07-310USD2284
2011-08-01 to 2012-07-310USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-08-01 to 2013-07-310USD365
2007-05-01 to 2013-07-31581,225USD2284
2011-08-01 to 2012-07-31500,000USD366

Inspect the source

Entity
THC THERAPEUTICS, INC. / CIK 0001404935
Captured
2026-09-21T17:18:57.388Z
SEC response SHA-256
f4626d642848143dc14fec3fdbe81fdaf088917037c5da7ecb43246b70ad052b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001404935.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))